BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol 2014; 20(23): 7223-7230 [PMID: 24966593 DOI: 10.3748/wjg.v20.i23.7223] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen MH. Reply. Hepatology 2020;71:1519. [PMID: 30762889 DOI: 10.1002/hep.30560] [Reference Citation Analysis]
2 Pereira LMS, da Silva Graça Amoras E, da Silva Conde SRS, Demachki S, Dos Santos EJM, Lima SS, Ishak R, Rosário Vallinoto AC. NGF (-198C > T, Ala35Val) and p75NTR (Ser205Leu) gene mutations are associated with liver function in different histopathological profiles of the patients with chronic viral hepatitis in the Brazilian Amazon. Mol Med 2020;26:12. [PMID: 31996124 DOI: 10.1186/s10020-019-0134-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lauridsen MM, Poulsen L, Rasmussen CK, Høgild M, Nielsen M, de Muckadell OBS, Vilstrup H. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy. Metab Brain Dis 2016;31:267-72. [DOI: 10.1007/s11011-015-9741-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
4 Hodgson A, Bernardin T, Westermeyer B, Hagopian E, Radtke T, Noman A. Development of a specialty intensity score to estimate a patient's need for care coordination across physician specialties. Health Sci Rep 2021;4:e303. [PMID: 34084946 DOI: 10.1002/hsr2.303] [Reference Citation Analysis]
5 Quinlan JI, Dhaliwal A, Williams F, Allen SL, Breen L, Greig CA, Lord JM, Armstrong MJ, Elsharkawy AM. Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease. Front Physiol 2021;12:817152. [PMID: 35242045 DOI: 10.3389/fphys.2021.817152] [Reference Citation Analysis]
6 Choudry N, Sasso R, Rockey DC. Infection in Hospitalized Cirrhosis Patients: Changing Epidemiology and Clinical Features. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.10.023] [Reference Citation Analysis]
7 Shkodra B, Press AT, Vollrath A, Nischang I, Schubert S, Hoeppener S, Haas D, Enzensperger C, Lehmann M, Babic P, Benecke KJ, Traeger A, Bauer M, Schubert US. Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I. Pharmaceutics 2020;12:E1110. [PMID: 33218172 DOI: 10.3390/pharmaceutics12111110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Poovorawan K, Treeprasertsuk S, Thepsuthammarat K, Wilairatana P, Kitsahawong B, Phaosawasdi K. The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study. Ann Hepatol 2015;14:862-8. [PMID: 26436358 DOI: 10.5604/16652681.1171773] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
9 Dashputre AA, Nemecek BD, Kamal KM, Covvey JR. The relationship between a cirrhosis-specific comorbidity scoring system and healthcare utilization patterns. J Gastroenterol Hepatol 2019;34:1222-30. [PMID: 30394572 DOI: 10.1111/jgh.14531] [Reference Citation Analysis]
10 Xiong J, Xu W, Huang H, Bian J, Wang A, Bai Y, Lin J, Xu Y, Lu X, Zhao H. Cirrhosis and risk of stroke: A systematic review and meta-analysis. Atherosclerosis 2018;275:296-303. [DOI: 10.1016/j.atherosclerosis.2018.06.876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Spring A, Saran JS, McCarthy S, McCluskey SA. Anesthesia for the Patient with Severe Liver Failure. Anesthesiol Clin 2020;38:35-50. [PMID: 32008656 DOI: 10.1016/j.anclin.2019.10.002] [Reference Citation Analysis]
12 Vural A, Attaway A, Welch N, Zein J, Dasarathy S. Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patients. Clin Nutr 2020;39:3711-20. [PMID: 32303380 DOI: 10.1016/j.clnu.2020.03.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kang TW, Kong SY, Kang D, Kang MW, Kim YK, Kim SH, Sinn DH, Kim YA, Choi KS, Lee ES, Woo SM, Back JH, Guallar E, Cho J. Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis. Radiology 2020;295:114-24. [PMID: 32013789 DOI: 10.1148/radiol.2020190639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 De Vincentis A, Pennazza G, Santonico M, Vespasiani-Gentilucci U, Galati G, Gallo P, Zompanti A, Pedone C, Antonelli Incalzi R, Picardi A. Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients. Liver Int. 2017;37:242-250. [PMID: 27496750 DOI: 10.1111/liv.13214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Pant C, Olyaee M, Gilroy R, Pandya PK, Olson JC, Oropeza-Vail M, Rai T, Deshpande A. Emergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011. Medicine (Baltimore). 2015;94:e308. [PMID: 25569646 DOI: 10.1097/md.0000000000000308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
16 Daş M, Bardakci O, Akdur G, Kankaya İ, Bakar C, Akdur O, Beyazit Y. Prediction of mortality with Charlson Comorbidity Index in super-elderly patients admitted to a tertiary referral hospital. Cukurova Medical Journal 2022;47:199-207. [DOI: 10.17826/cumj.1017164] [Reference Citation Analysis]
17 Wu HY, Lin CS, Yeh CC, Hu CJ, Shih CC, Cherng YG, Chen TL, Liao CC. Cirrhosis patients' stroke risks and adverse outcomes: Two nationwide studies. Atherosclerosis 2017;263:29-35. [PMID: 28599256 DOI: 10.1016/j.atherosclerosis.2017.05.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sasso R, Lauzon S, Rockey DC. Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and Survival. Dig Dis Sci 2020;65:3744-52. [PMID: 31960201 DOI: 10.1007/s10620-020-06051-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Samant TS, Yang S, Miller M, Ji Y. Pharmacokinetics of Ribociclib in Subjects With Hepatic Impairment. J Clin Pharmacol 2021;61:1001-9. [PMID: 33555033 DOI: 10.1002/jcph.1825] [Reference Citation Analysis]
20 Rogal SS, Yakovchenko V, Gonzalez R, Park A, Lamorte C, Gibson SP, Chartier M, Ross D, Comstock E, Bajaj JS, Morgan TR. Characterizing patient-reported outcomes in veterans with cirrhosis. PLoS One 2020;15:e0238712. [PMID: 32915828 DOI: 10.1371/journal.pone.0238712] [Reference Citation Analysis]
21 Rudler M, Marois C, Weiss N, Thabut D, Navarro V; Brain-Liver Pitié-Salpêtrière Study Group (BLIPS). Status epilepticus in patients with cirrhosis: How to avoid misdiagnosis in patients with hepatic encephalopathy. Seizure 2017;45:192-7. [PMID: 28092846 DOI: 10.1016/j.seizure.2016.12.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Tantai XX, Liu N, Yang LB, Wei ZC, Xiao CL, Song YH, Wang JH. Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding. World J Gastroenterol 2019; 25(45): 6668-6680 [PMID: 31832005 DOI: 10.3748/wjg.v25.i45.6668] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
23 Sasidharan Nair GV, Mathen PG, Pillai MG, Gireesh Kumar KP, Velayudhan KK, Sreekrishnan TP. Initial choice of antibiotic in recurrent spontaneous bacterial peritonitis: A retrospective study. Int J Crit Illn Inj Sci 2019;9:187-90. [PMID: 31879606 DOI: 10.4103/IJCIIS.IJCIIS_49_18] [Reference Citation Analysis]
24 Spring A, Saran JS, McCarthy S, McCluskey SA. Anesthesia for the Patient with Severe Liver Failure. Adv Anesth 2020;38:251-67. [PMID: 34106838 DOI: 10.1016/j.aan.2020.09.002] [Reference Citation Analysis]
25 Sasso R, Abou Yassine A, Deeb L. Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury. J Clin Med 2021;10:5621. [PMID: 34884323 DOI: 10.3390/jcm10235621] [Reference Citation Analysis]
26 Hayward KL, Weersink RA. Improving Medication-Related Outcomes in Chronic Liver Disease. Hepatol Commun 2020;4:1562-77. [PMID: 33163829 DOI: 10.1002/hep4.1612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Mu XM, Wang W, Jiang YY, Feng J. Patterns of Comorbidity in Hepatocellular Carcinoma: A Network Perspective. Int J Environ Res Public Health 2020;17:E3108. [PMID: 32365650 DOI: 10.3390/ijerph17093108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tergast TL, Laser H, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites. Clin Transl Gastroenterol 2018;9:189. [PMID: 30250034 DOI: 10.1038/s41424-018-0053-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
29 Saberifiroozi M. Improving Quality of Care in Patients with Liver Cirrhosis. Middle East J Dig Dis 2017;9:189-200. [PMID: 29255576 DOI: 10.15171/mejdd.2017.73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Licata A, Novo G, Colomba D, Tuttolomondo A, Galia M, Camma' C. Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis. J Cardiovasc Med (Hagerstown). 2016;17:26-36. [PMID: 26065511 DOI: 10.2459/JCM.0000000000000288] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Kichloo A, El-Amir Z, Dahiya DS, Wani F, Singh J, Solanki D, Edigin E, Eseaton P, Mehboob A, Shaka H. Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions. World J Hepatol 2021; 13(12): 2128-2136 [DOI: 10.4254/wjh.v13.i12.2128] [Reference Citation Analysis]
32 Yu S, Long Y, Li D, Shi A, Deng J, Ma Y, Wen J, Li X, Zhang Y, Liu S, Wan J, Li N, Guo J. Natural essential oils efficacious in internal organs fibrosis treatment: mechanisms of action and application perspectives. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106339] [Reference Citation Analysis]
33 Abraham JA, Golubnitschaja O. Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon? Per Med 2016;13:455-67. [PMID: 29767598 DOI: 10.2217/pme-2016-0013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]